Challenges and Opportunities in State‐of‐the‐Art Proteomics Analysis for Biomarker Development From Plasma Extracellular Vesicles
Authors:
- Panshak P. DakupPDPanshak P. Dakup
- Ivo Diaz LudovicoILIvo Diaz Ludovico
- Youngki YouYYYoungki You
- Chaitra RaoChaitra Rao
- Javier FloresJFJavier Flores
- Lisa M. BramerLisa M. Bramer
- Marian RewersMRMarian Rewers
- Bobbie‐Jo M. Webb‐RobertsonBWBobbie‐Jo M. Webb‐Robertson
- Thomas O. MetzTMThomas O. Metz
- Raghavendra G. MirmiraRaghavendra G. Mirmira
- Emily K. SimsESEmily K. Sims
- Ernesto S. NakayasuENErnesto S. Nakayasu
Open Access
- 16 September 2025
- journal article
- Published by Wiley in Proteomics
- Vol. 26 (2-3) , 9-20
Abstract
Extracellular vesicles (EVs) are membrane‐bound particles secreted by cells, playing crucial roles in intercellular communication. The composition of EVs can undergo changes in response to stress and disease conditions, making them excellent biomarker candidates. However, extracting protein information from EVs can be challenging due to their low abundance in complex biofluids and copurification with contaminant proteins and particles. Techniques to enrich EVs have their strengths and limitations, without one being able to purify EVs to complete homogeneity. This can lead to compromised recovery rates and increased complexity, making data interpretation difficult. In this viewpoint article, we explore the concept that better characterization of EV composition, followed by quantification of EV proteins in complex samples, might be a more viable route for biomarker development. Mass spectrometers can provide reproducible deep coverage of the EV proteome, despite sample impurities. This paradigm shift presents opportunities to integrate advanced bioinformatics tools to refine the EV proteome landscape, identify novel biomarkers, and streamline validation processes in biomarker development. By focusing on leveraging technology rather than achieving absolute purity, this approach can transform current practices and open opportunities for robust biomarker discovery. Herein, we highlight not only such opportunities but also challenges to implement this concept. Summary: Extracellular vesicles (EVs) have enormous potential as biomarkers of diseases, as they can carry signatures of the cells they are derived from and the pathogenesis process. Biofluids, such as blood plasma, are highly complex and contain many components with physicochemical properties similar to those of EVs, making it challenging to obtain pure EV fractions. Challenges in obtaining pure preparations represent a main hurdle for studying EVs, and their components are potential biomarkers. This article explores the concept of studying EV proteins within complex samples, discussing opportunities and needs to move this field forward.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK138335)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK133881)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK127505)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK127786)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK060581)
This publication has 84 references indexed in Scilit:
- Enhanced proteomic profiling of human plasma‐derived extracellular vesicles through charge‐based fractionation to advance biomarker discovery potentialJournal of Extracellular Vesicles, 2024
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Scalable purification of extracellular vesicles with high yield and purity using multimodal flowthrough chromatographyJournal of Extracellular Biology, 2024
- Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson DiseaseJAMA Neurology, 2024
- Building predictive disease models using extracellular vesicle microscale flow cytometry and machine learningMolecular Oncology, 2022
- A guide to mass spectrometric analysis of extracellular vesicle proteins for biomarker discoveryMass Spectrometry Reviews, 2021
- Robust sequential biophysical fractionation of blood plasma to study variations in the biomolecular landscape of systemically circulating extracellular vesicles across clinical conditionsJournal of Extracellular Vesicles, 2021
- α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's DiseaseMovement Disorders, 2021
- Integrated Dual‐Mode Chromatography to Enrich Extracellular Vesicles from PlasmaAdvanced Biosystems, 2020
- Exosomes and Microvesicles: Identification and Targeting By Particle Size and Lipid Chemical ProbesChemBioChem, 2014